0001752724-21-022505.txt : 20210216 0001752724-21-022505.hdr.sgml : 20210216 20210216090203 ACCESSION NUMBER: 0001752724-21-022505 CONFORMED SUBMISSION TYPE: N-CEN PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20201130 FILED AS OF DATE: 20210216 DATE AS OF CHANGE: 20210216 EFFECTIVENESS DATE: 20210216 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Copeland Trust CENTRAL INDEX KEY: 0001502745 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: N-CEN SEC ACT: 1940 Act SEC FILE NUMBER: 811-22483 FILM NUMBER: 21633091 BUSINESS ADDRESS: STREET 1: 1400 PEOPLES PLAZA STREET 2: SUITE 104 CITY: NEWARK STATE: DE ZIP: 19702 BUSINESS PHONE: 617-399-6935 MAIL ADDRESS: STREET 1: 1400 PEOPLES PLAZA STREET 2: SUITE 104 CITY: NEWARK STATE: DE ZIP: 19702 FORMER COMPANY: FORMER CONFORMED NAME: Edgartown Trust DATE OF NAME CHANGE: 20101004 0001502745 S000030695 Copeland Dividend Growth Fund C000095114 Copeland Dividend Growth Fund Class A shares CDGRX C000109647 Copeland Dividend Growth Fund Class C shares CDCRX C000124573 Copeland Dividend Growth Fund Class I shares CDIVX 0001502745 S000056507 Copeland SMID Cap Dividend Growth Fund C000178802 Copeland SMID Cap Dividend Growth Fund Class I Shares CSMDX C000209896 Copeland SMID Cap Dividend Growth Fund Class A Shares CSDGX N-CEN 1 primary_doc.xml X0303 N-CEN LIVE 0001502745 XXXXXXXX 811-22483 N-1A S000056507 C000178802 C000209896 S000030695 C000095114 C000109647 C000124573 Copeland Trust 811-22483 0001502745 5493005MVJ95H6N82870 161 Washington Street Eight Tower Bridge Suite 1325 Conshohocken 19428 US-PA US 484-351-3700 Northern Lights Distrbutors 4221 North 203rd Street, Suite 100 Elkhorn 68022 631-470-2600 Relating to its functions as Distributor and principal underwriter of the Funds Copeland Capital Management, LLC. 161 Washington Street Conshohocken 19428 484-351-3700 Relating to its functions as Adviser to the Funds. The Northern Trust Company 50 South LaSalle Street Chicago 60603 312-630-6000 Relating to its functions as custodian and record keeping Gemini Fund Services 4221 North 203rd Street, Suite 100 Elkhorn 68022 631-470-2600 Relating to its functions as Administrator, Shareholder Servicing Agent and Accounting and Transfer Agent Records N N N N-1A 2 Y Stephen M. Wynne N/A N Ted Rorer N/A Y Thomas A. Leonard N/A N Bruce M. Aronow N/A N Sofia A. Rosala N/A 161 Washington Street Suite 1325 Conshohocken 68130 XXXXXX N N N N N N N Northern Lights Distributors 8-065857 N/A N/A N N Tait, Weller & Baker LLP 445 N/A N N N N N N N Copeland SMID Cap Dividend Growth Fund S000056507 549300FTMTF6WH841Y37 N 2 0 0 N/A N N Y N N/A 0.00000000 0.00000000 Rule 32a-4 (17 CFR 270.32a-4) Y Y Y N Copeland Capital Management LLC 801-22483 N/A N/A N Gemini Fund Services, LLC 84-1964 N/A N N N ICE Data Services N/A N N The Northern Trust Company 6PTKHDJ8HDUF78PFWH30 N N Bank - section 17(f)(1) (15 U.S.C. 80a-17(f)(1)) N Gemini Fund Services, LLC 84-06083 Filing Number Y N N Gemini Fund Services, LLC 84-06083 Filing Number Y N N Robert W. Baird & Co. 8-00497 000008158 549300772UJAHRD6LO53 281.00000000 Raymond James 8-17983 000006694 ZXMJHJK466PBZTM5F379 2463.00000000 Oppenheimer & Co. 8-4077 000000249 N/A 439.00000000 JPMorgan Chase 8-35008 000000079 8I5DZWZKVSZI1NUHU748 368.00000000 Instinet, Inc. 8-23669 000007897 549300MGMN3RKMU8FT57 8825.00000000 Morgan Stanley 8-15869 000008209 9R7GPTSO7KV3UQJZQ078 434.00000000 Liquidnet 8-52461 000103987 213800HSKBBO1GCVRG79 843.00000000 ISI Group 8-49830 000042405 3912008OD2LKOC3EK682 309.00000000 Alliancebernstein 8-30851 000014549 0JK55UGWSWNF3X7KLQ85 593.00000000 Goldman Sachs 8-129 000000361 784F5XWPLTWKTBV3E584 609.00000000 16473.00000000 0 N 14729606.00000000 N N N N Copeland Risk Managed Dividend Growth Fund S000030695 549300KVFXT7DVDGME23 N 3 0 0 N/A N N Y N N/A 0.00000000 0.00000000 Rule 22d-1 (17 CFR 270.22d-1) Y Y Y N Copeland Capital Management LLC 801-22483 N/A N/A N Gemini Fund Services, LLC 84-1964 N/A N N N ICE Data Services N/A N N The Northern Trust Company 6PTKHDJ8HDUF78PFWH30 N N Bank - section 17(f)(1) (15 U.S.C. 80a-17(f)(1)) N Gemini Fund Services, LLC 84-06083 Filing Number Y N N Gemini Fund Services, LLC 84-06083 Filing Number Y N N Royal Bank of Canada Capital Markets 8-39947 000022698 ES7IP3U3RHIGC71XBU11 9862.00000000 KBC Bank 8-51529 000046709 6B2PBRV1FCJDMR45RZ53 2974.00000000 Goldman Sachs 8-129 000000361 FOR8UP27PHTHYVLBNG30 2739.00000000 Exane, Inc. 8-49569 000041784 6SDWK6FV8H98XAGSYS75 12626.00000000 Instinet, Inc. 8-23669 000007897 549300MGMN3RKMU8FT57 9451.00000000 Raymond James 8-17983 000006694 ZXMJHJK466PBZTM5F379 47892.00000000 William Blair & Co 8-02698 000001252 549300J0P7XYE8BMZ775 2637.00000000 Daiwa Securities 8-12242 000001576 549300OE1DCA4NYQ5H32 9146.00000000 SG Securities 8-68732 000155643 549300X7ULDGXKFTX656 17630.00000000 Berenberg 8-68821 000156757 5493007EG0CYRKKG9L11 2728.00000000 122559.00000000 Goldman Sachs 8-129 000000361 784F5XWPLTWKTBV3E584 57020501.00000000 Morgan Stanley 8-15869 000008209 9R7GPTSO7KV3UQJZQ078 38846717.00000000 JPMorgan Chase 8-35008 000000079 8I5DZWZKVSZI1NUHU748 65199117.00000000 161006336.00000000 N 87487687.00000000 N N N N true INTERNAL CONTROL RPT 2 Copeland_N-CEN.txt COPELAND FUNDS INTERNAL CONTROL LETTER 11.30.2020 REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM Shareholders and Board of Trustees Copeland Trust Conshohocken, PA In planning and performing our audits of the financial statements of Copeland Dividend Growth Fund and Copeland SMID Cap Dividend Growth Fund as of and for the year ended November 30, 2020, in accordance with the standards of the Public Company Accounting Oversight Board (United States), we considered their internal control over financial reporting, including control activities for safeguarding securities, as a basis for designing our auditing procedures for the purpose of expressing our opinion on the financial statements and to comply with the requirements of Form N-CEN, but not for the purpose of expressing an opinion on the effectiveness of the Trust's internal control over financial reporting. Accordingly, we express no such opinion. The management of the Trust is responsible for establishing and maintaining effective internal control over financial reporting. In fulfilling this responsibility, estimates and judgments by management are required to assess the expected benefits and related costs of controls. A company's internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance generally accepted accounting principles. A company's internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of a company's assets that could have a material effect on the financial statements. Because of inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate. A deficiency in internal control over financial reporting exists when the design or operation of a control does not allow management or employees, in the normal course of performing their assigned functions, to prevent or detect misstatements on a timely basis. A material weakness is a deficiency, or combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the company's annual or interim financial statements will not be prevented or detected on a timely basis. Shareholders and Board of Trustees Copeland Trust Page Two Our consideration of the Trust's internal control over financial reporting was for the limited purpose described in the first paragraph and would not necessarily disclose all deficiencies in internal control that might be material weaknesses under standards established by the Public Company Accounting Oversight Board (United States). However, we noted no deficiencies in the Trust's internal control over financial reporting and its operation, including controls for safeguarding securities, which we consider to be material weaknesses, as defined above, as of November 30, 2020. This report is intended solely for the information and use of management, Shareholders and Board of Trustees of Copeland Trust and the Securities and Exchange Commission, and is not intended to be and should not be used by anyone other than these specified parties. TAIT, WELLER & BAKER LLP Philadelphia, Pennsylvania January 29, 2021